Navigation Links
Jonathan Salkin Named Executive Vice President of Devicor Medical Products
Date:5/5/2009

Salkin joins former colleague Tom Daulton to provide strategic leadership as Devicor looks to make its first major acquisition

PLEASANT PRAIRIE, Wis., May 5 /PRNewswire/ -- Devicor Medical Products, LLC, today named Jonathan Salkin to serve as Executive Vice President, Corporate Development & Strategy. Salkin's most recent experience as a Managing Director at the Royal Bank of Scotland plc is highlighted by his successful launch of that Bank's first healthcare investment banking group globally. Prior to that, as Vice President of Corporate Development for Cardinal Health, Salkin was instrumental in strategic planning, mergers and acquisitions for Cardinal's $10 billion Medical Products & Services group.

It was at Cardinal that Salkin first connected with Tom Daulton, Devicor's CEO. "Jon brings the perfect blend of disciplines to Devicor," said Daulton. "His combined experience in the worlds of finance, strategy and healthcare will drive us forward as we work to build a market-leading medical device company."

Based in the New York City area, one of Salkin's primary responsibilities will be to work with Daulton to secure Devicor's initial platform acquisition as the company looks to acquire established interventional medical device businesses that manufacture and sell products to clinicians in settings such as hospitals, surgery centers, or physician offices. Beyond that, Salkin will work on strategic initiatives including subsequent mergers, acquisitions, and other collaborative endeavors; he is expected to take a leadership role in running certain segments of the day-to-day operations; and he'll serve on Devicor's Board of Directors.

"Having previously worked with Tom to successfully build a fast-growing, profitable business, I am thrilled to once again be his partner as Devicor deploys its substantial funding into products and companies that are advancing the field of interventional medicine and lowering overall healthcare costs," Salkin said.

Devicor was formed in partnership with GTCR, one of the nation's leading private equity firms, which plans to invest up to $250 million of equity capital to support the company's strategy.

Salkin previously worked for Dresdner Kleinwort Wasserstein (formerly Wasserstein Perella & Co.) as Director of Healthcare Mergers & Acquisitions, and in the Mergers, Acquisitions and Corporate Advisory Group at Deutsche Bank. He received a BA, MBA, and JD from Case Western Reserve University in Cleveland, Ohio.

About Devicor Medical Products, LLC

Devicor Medical Products, headquartered in Pleasant Prairie, Wisconsin, is a global medical device company focused on acquiring and developing clinical preference medical devices and companies. For more information, please visit www.devicormedical.com or call (262) 857-9300.

About GTCR

Founded in 1980, GTCR Golder Rauner, LLC is a leading private equity investment firm and long-term strategic partner for outstanding management teams. The Chicago-based firm pioneered the investment strategy of identifying and partnering with exceptional executives to acquire and build companies through a combination of acquisitions and strong internal growth. GTCR currently manages more than $8 billion of equity capital invested in a wide range of companies and industries. More information about GTCR can be found at www.gtcr.com.


'/>"/>
SOURCE Devicor Medical Products, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Jonathan Finder, M.D., Joins Point Pleasant Pediatric Special Cares Medical Management Team as Pulmonary Consultant
2. Dr. Jonathan White Joins Haemonetics as Head of Research and Development
3. Emmy Winner Jonathan Jackson With Rock Band Enation Take On Predators & Rapists
4. Jonathan Jacobson Appointed General Manager, Global Business Strategies & Operations, Menicon Co., Ltd.
5. Jailed Indian Pediatrician Wins 2008 Jonathan Mann Award for Global Health and Human Rights
6. Pixantrone Now Available in Europe on a Named-Patient Basis
7. PartsSource Named Team NEO Winner for 2009
8. Junghans named PI in $5.9 million breast cancer grant
9. Aging Advocate Named President of Marylands Leading Long-Term Care Association
10. Fargo Named Americas Cleanest City in American Lung Associations State of the Air Report
11. Robert J. Gould Named President at Partnership for Prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their ... Award, an essay contest in which patients and their families pay tribute to a ... the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors Luke’s ... June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. ... helping service members that have been wounded in battle and their families. Venture Construction ...
(Date:6/24/2016)... ... June 24, 2016 , ... Finally, a bruise cream that ... dermaka cream can be incorporated into the post-surgical treatment plans of a variety of ... , dermaka cream is very effective for bruising and causes a rapid resolution of ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Today, ... optimize the ingestion of their medication by matching users with high quality water pipes ... compare pieces with no commitment. , Inhale was founded by two brothers, Nick and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
Breaking Medicine Technology: